Details for New Drug Application (NDA): 016016
✉ Email this page to a colleague
NDA 016016 describes ALDOCLOR-250, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the ALDOCLOR-250 profile page.
The generic ingredient in ALDOCLOR-250 is chlorothiazide; methyldopa. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; methyldopa profile page.
The generic ingredient in ALDOCLOR-250 is chlorothiazide; methyldopa. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; methyldopa profile page.
Summary for 016016
| Tradename: | ALDOCLOR-250 |
| Applicant: | Merck |
| Ingredient: | chlorothiazide; methyldopa |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 150MG;250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG;250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
